Osmotica Study Site-141 — New York, New York

Osmotica Study Site-141 is a clinical research site located in New York, New York, United States 10019.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Osmotica Study Site-141 has participated in 1 clinical trials.

Therapeutic areas: Spasticity, Multiple Sclerosis.

Sponsors: RVL Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Osmotica Study Site-141?

Osmotica Study Site-141 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Osmotica Study Site-141 conducted?

Osmotica Study Site-141 has 1 clinical trials on record. Their work covers Spasticity, Multiple Sclerosis.

Is Osmotica Study Site-141 accredited by Crixeo Health?

Osmotica Study Site-141 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Osmotica Study Site-141?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.